World's Best Scientists 2026 revealed!
Danuta S. Kalinowski

Danuta S. Kalinowski

D-Index & Metrics

Biology and Biochemistry

D-Index
59
Citations
22609
World Ranking
12265
National Ranking
341

Chemistry

D-Index
55
Citations
11330
World Ranking
12087
National Ranking
277

Danuta S. Kalinowski publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Danuta S. Kalinowski sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 113 publications — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Danuta S. Kalinowski D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Danuta S. Kalinowski sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 55 D-Index — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Danuta S. Kalinowski is affiliated with the University of Sydney in Australia and has contributed to research primarily within the field of Biochemistry, Genetics and Molecular Biology. Their work spans several subfields of study including Molecular Biology, Physiology, Cell Biology, Cellular and Molecular Neuroscience, and Epidemiology.

The scientist's recent research topics encompass a range of areas related to cellular function and disease mechanisms. These topics include:

  • Calcium signaling and nucleotide metabolism
  • Lipid Membrane Structure and Behavior
  • Cellular transport and secretion
  • Genetic Neurodegenerative Diseases
  • Mitochondrial Function and Pathology
  • Autophagy in Disease and Therapy
  • Franz Kafka Literary Studies

Among their recent publications, Danuta S. Kalinowski's authored paper includes:

  • Franz Kafka in the Comic. Description of some Examples, 2022, Mìžnarodnij fìlologìčnij časopis

Other research papers in which they are listed as an author or co-author cover topics such as drug resistance mechanisms and therapeutic strategies in genetic diseases, published in venues like Future Medicinal Chemistry and Pharmacological Research:

  • The Growing Evidence for Targeting P-Glycoprotein in Lysosomes to Overcome Resistance, 2020, Future Medicinal Chemistry
  • The potential of the novel NAD+ supplementing agent, SNH6, as a therapeutic strategy for the treatment of Friedreich's ataxia, 2020, Pharmacological Research
  • Seroprevalence of equine leptospirosis in Poland (2019-2023), 2025, Equine Veterinary Journal

Frequent collaborators in their research include Mahendiran Dharmasivam, Des R. Richardson, Sven Marcel Stefan, Patric J. Jansson, and Rukhsana Anjum. Their collective work has appeared across a variety of publication venues such as:

  • Future Medicinal Chemistry
  • Pharmacological Research
  • Mìžnarodnij fìlologìčnij časopis
  • Equine Veterinary Journal

The scientist's work integrates diverse topics in molecular biology and neuroscience with interdisciplinary interests that extend even into literary studies related to Franz Kafka. This combination of focus areas indicates a broad scholarly scope crossing both life sciences and humanities.

Best Publications

  • Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

    Daniel J. Klionsky;Amal Kamal Abdel-Aziz;Sara Abdelfatah;Mahmoud Abdellatif

  • The Evolution of Iron Chelators for the Treatment of Iron Overload Disease and Cancer

    Danuta S. Kalinowski;Des R. Richardson

  • Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.

    Phatsapong Yingchoncharoen;Danuta S. Kalinowski;Des R. Richardson

  • Unraveling the mysteries of serum albumin—more than just a serum protein

    Angelica M. Merlot;Danuta S. Kalinowski;Des R. Richardson

  • Thiosemicarbazones from the old to new: iron chelators that are more than just ribonucleotide reductase inhibitors

    Yu Yu;Danuta S. Kalinowski;Zaklina Kovacevic;Aritee R. Siafakas

  • Dipyridyl thiosemicarbazone chelators with potent and selective antitumor activity form iron complexes with redox activity.

    Des R. Richardson;Philip C. Sharpe;David B. Lovejoy;Dakshita Senaratne

  • Cellular iron uptake, trafficking and metabolism: Key molecules and mechanisms and their roles in disease.

    D.J.R. Lane;A.M. Merlot;M.L.-H. Huang;D.-H. Bae

  • Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents

    D.R. Richardson;D.S. Kalinowski;S. Lau;P.J. Jansson

  • Design, Synthesis, and Characterization of Novel Iron Chelators: Structure−Activity Relationships of the 2-Benzoylpyridine Thiosemicarbazone Series and Their 3-Nitrobenzoyl Analogues as Potent Antitumor Agents

    Danuta S Kalinowski;Yu Yu;Philip C Sharpe;Mohammad Islam

  • Chelators at the cancer coalface: desferrioxamine to Triapine and beyond.

    Yu Yu;Jacky Wong;David B. Lovejoy;Danuta S. Kalinowski

  • Novel second-generation di-2-pyridylketone thiosemicarbazones show synergism with standard chemotherapeutics and demonstrate potent activity against lung cancer xenografts after oral and intravenous administration in vivo.

    David B. Lovejoy;Danae M. Sharp;Nicole Seebacher;Peyrnan Obeidy

  • 2-Acetylpyridine Thiosemicarbazones are Potent Iron Chelators and Antiproliferative Agents: Redox Activity, Iron Complexation and Characterization of their Antitumor Activity

    Des R. Richardson;Danuta S. Kalinowski;Vera Richardson;Philip C. Sharpe

  • Roads to melanoma: Key pathways and emerging players in melanoma progression and oncogenic signaling.

    Jasmina Paluncic;Zaklina Kovacevic;Patric J. Jansson;Danuta Kalinowski

  • Thiosemicarbazones: the new wave in cancer treatment.

    Danuta S Kalinowski;Patricia Quach;Des R Richardson

  • Novel Chelators for Cancer Treatment: Where Are We Now?

    Angelica M. Merlot;Danuta S. Kalinowski;Des R. Richardson

  • Investigating biological activity spectrum for novel styrylquinazoline analogues.

    Josef Jampilek;Robert Musiol;Jacek Finster;Matus Pesko

  • Iron chelators of the dipyridylketone thiosemicarbazone class: precomplexation and transmetalation effects on anticancer activity.

    Paul V. Bernhardt;Philip C. Sharpe;Mohammad Islam;David B. Lovejoy

  • Future of toxicology--iron chelators and differing modes of action and toxicity: the changing face of iron chelation therapy.

    Danuta S. Kalinowski;Des R. Richardson

  • Zinc(II)–Thiosemicarbazone Complexes Are Localized to the Lysosomal Compartment Where They Transmetallate with Copper Ions to Induce Cytotoxicity

    Alexandra E. Stacy;Duraippandi Palanimuthu;Paul V. Bernhardt;Danuta S. Kalinowski

  • Targeting cancer by binding iron: Dissecting cellular signaling pathways

    Goldie Y.L. Lui;Zaklina Kovacevic;Vera Richardson;Angelica M. Merlot

Frequent Co-Authors

Des R. Richardson
Des R. Richardson Griffith University
Paul V. Bernhardt
Paul V. Bernhardt University of Queensland
Josef Jampilek
Josef Jampilek University of Silesia
Michael J. Davies
Michael J. Davies University of Copenhagen
Naresh Kumar
Naresh Kumar University of New South Wales
Victor R. Gordeuk
Victor R. Gordeuk University of Illinois at Chicago
Roger J. W. Truscott
Roger J. W. Truscott University of Wollongong
Shinya Toyokuni
Shinya Toyokuni Nagoya University
Vladimir N. Uversky
Vladimir N. Uversky University of South Florida
Fatah Kashanchi
Fatah Kashanchi George Mason University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry in the USA opens the door to a wide range of online degree options and healthcare career pathways. For those seeking flexibility and financial support, medical assistant classes online with financial aid can be a smart starting point. These programs provide foundational healthcare training while keeping costs manageable.

Many students also choose to advance their credentials. Consider a cma to lpn bridge program online if you want to transition from a medical assistant role to becoming a licensed practical nurse. This pathway offers flexibility and can enhance your job prospects across various clinical settings.

If your passion lies in scientific research or applied biology, you can pursue online biology degrees, many of which offer accelerated options for motivated learners. Alternatively, those interested in nursing can enroll in an asn program online to gain essential nursing skills and credentials, all while studying at your own pace. Each of these online pathways can help you build a rewarding career in medicine, research, or healthcare.

Best Scientists Citing Danuta S. Kalinowski

Trending Scientists

Recently Published Articles